Raul Santos: Sex Differences And Similarities in the Management of Familial Hypercholesterolemia During Life Course
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn:
“Delighted to share our new editorial, ‘Sex differences and similarities in the management of familial hypercholesterolemia during the life course: learning from the younglings,’ now available in Atherosclerosis. Building on the elegant study by Jan Kafol, Urh Groselj, and colleagues on sex differences in cholesterol levels among prepubertal children in Slovenia, we highlight how the genetic burden of FH can override normal physiological sex differences and why universal pediatric screening is so important.
Together with Prof. Mariko Harada-Shiba, we argue for a truly life-course and sex-sensitive approach to FH care – from early diagnosis and statin initiation in childhood, through pregnancy management, to intensifying lipid-lowering after menopause – so we can meaningfully reduce ASCVD risk for both women and men living with FH.”
Title: Sex Differences and similarities in the Management of Familial Hypercholesterolemia during life course: learning from the younglings
Authors: Mariko Harada-Shiba, Raul D. Santos
Read full study here.
Stay updated with Hemostasis Today.
-
Nov 24, 2025, 10:25Jean Jacques Kiladjian Visits INSERM-supervised CIC 1408 Investigation Center
-
Nov 24, 2025, 10:06Amirpasha Moetazedian Invites a PHD Student to His Lab to Explore Sustainable Artificial Blood Vessels
-
Nov 24, 2025, 09:41Kamran Hajiyev Reflects on A Week of Innovation, Collaboration, and Scientific Exchange at SVIN 2025
-
Nov 24, 2025, 02:55Do You Know Why Clot Contracts? Marin Pavlov Reflects on Expert PE Conference 2025
-
Nov 24, 2025, 01:39Ashkan Shoamanesh Shares OCEANIC-STROKE Trial’s Successful Endpoints
-
Nov 24, 2025, 01:10Swarsat K Nath on HemeNext 2025: AI is Real, Measurable, and Already Changing Lives
-
Nov 23, 2025, 15:15Dirk Sibbing on OCEANIC-STROKE Demonstrationg Superiority of Asundexian vs. Placebo
-
Nov 23, 2025, 14:57Jesse Landry on SeraGene Therapeutics: Rewriting the Rules of Blood and Bleeding Disorders
-
Nov 23, 2025, 14:49Reza Shojaei: What Truly Motivates Donors And What Keeps Them Coming Back?